Introducing Single Dose Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis in Rural Bangladesh: Feasibility and Acceptance to Patients and Health Staff
Table 3
Patients’ experiences and perceived benefits by the sLAB and miltefosine treatment regimen.
Indicator
sLAB
Miltefosine
value
Resolution of fever in days, mean (SD)
2.48 (0.86)
17.58 (11.34)
<0.001
Nausea/vomiting after treatment % ()
1.3 (4)
86.4 (19)
<0.001
Diarrhoea % ()
0.00 (0)
63.6 (14)
<0.001
Abdominal pain % ()
0.7 (2)
27.3 (6)
<0.001
Mean of time to recovery in days (SD)
2.39 (0.731)
17.36 (12.385)
<0.001
Mean of time in days to start working after treatment (SD)
2.72 (1.819)
52.82 (33.987)
<0.001
Income loss due to recovery time
2.72 days 0.30$1/day = 0.816$
52.82 days 0.30$1/day = 15.846$
<0.001
Income loss (working days lost when receiving treatment)
2.39 days 0.3$/d = 0.72$
17.36 days 0.3$/d = 5.2$
<0.001
Average daily income per person in a VL affected household in Bangladesh, calculated by Anoopa Sharma et al. 2006 [10].
